For the full year, the company's consolidated net profit rose 4.78% to Rs 454.85 crore while net sales declined 10.23% to Rs 2485.38 crore in the year ended March 2025 over the year ended March 2024. PBT rose 5.98% to Rs 613.50 crore in FY25.
The company's consolidated net cash from operating activities stood at Rs 583.59 crore in FY25, higher than Rs 440.39 crore in FY24.
The company's board recommended a total dividend of Rs 12 per equity share for the year ended 31 March 2025.
Linde India is primarily engaged in manufacture of industrial and medical gases and construction of cryogenic and non-cryogenic air separation plants.